Journal of Diagnostics Concepts & Practice ›› 2020, Vol. 19 ›› Issue (05): 450-453.doi: 10.16150/j.1671-2870.2020.05.002
• Experts forum • Previous Articles Next Articles
Received:
2020-07-01
Online:
2020-10-25
Published:
2022-07-14
CLC Number:
项目 | 疑似原醛患者 (n=218) |
---|---|
女性[n(%)] | 135(61.9) |
年龄(岁) | 56.8±18.2 |
筛查原因[n(%)] | |
持续性血压>160/100 mmHg或难治性高血压 | 100(45.9) |
高血压合并自发性或利尿剂所致的低血钾 | 47(21.6) |
高血压合并肾上腺意外瘤 | 27(12.4) |
早发高血压或脑卒中家族史的高血压患者 | 25(11.5) |
高血压合并阻塞型呼吸睡眠暂停综合征[n(%)] | 27(12.4) |
原醛患者的一级亲属中患高血压者[n(%)] | 13(6.0) |
ARR检测[n(%)] | |
坐位或立位 | 153(70.2) |
卧位 | 49(22.5) |
坐位或立位+卧位 | 16(7.3) |
确诊试验[n(%)] | 109(50.0) |
卡托普利试验 | 73(33.5) |
静脉生理盐水滴注试验 | 32(14.7) |
卡托普利+静脉生理盐水滴注试验 | 4(1.8) |
血检查指标 | |
血钾(mmol/L) | 3.76±0.58 |
肌酐(μmol/L) | 62.30±15.20 |
尿酸(μmol/L) | 308.00±94.00 |
三酰甘油(mmol/L) | 1.86±1.45 |
总胆固醇(mmol/L) | 4.59±1.22 |
高密度脂蛋白胆固醇(mmol/L) | 1.21±0.37 |
低密度脂蛋白胆固醇(mmol/L) | 2.63±0.81 |
合并疾病[n(%)] | |
脑卒中 | 48(22.0) |
冠心病 | 39(17.9) |
糖尿病 | 42(19.3) |
[1] |
Rimoldi SF, Scherrer U, Messerli FH. Secondary arterial hypertension: when, who, and how to screen?[J]. Eur Heart J. 2014 May 14; 35(19):1245-1254.
doi: 10.1093/eurheartj/eht534 |
[2] |
Hundemer GL, Vaidya A. Primary aldosteronism diagnosis and management: a clinical approach[J]. Endocrinol Metab Clin North Am, 2019, 48(4):681-700.
doi: 10.1016/j.ecl.2019.08.002 URL |
[3] |
Käyser SC, Dekkers T, Groenewoud HJ, et al. Study hete-rogeneity and estimation of prevalence of primary aldosteronism: a systematic review and meta-regression analysis[J]. J Clin Endocrinol Metab, 2016, 101(7):2826-2835.
doi: 10.1210/jc.2016-1472 URL |
[4] |
Monticone S, Burrello J, Tizzani D, et al. Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice[J]. J Am Coll Cardiol, 2017, 69(14):1811-1820.
doi: S0735-1097(17)30569-7 pmid: 28385310 |
[5] |
Umpierrez GE, Cantey P, Smiley D, et al. Primary aldosteronism in diabetic subjects with resistant hypertension[J]. Diabetes Care, 2007, 30(7):1699-1703.
doi: 10.2337/dc07-0031 URL |
[6] |
Prejbisz A, Florczak E, Klisiewicz A, et al. Relationship between primary aldosteronism and obstructive sleep apnoea, metabolic abnormalities and cardiac structure in patients with resistant hypertension[J]. Endokrynol Pol, 2013, 64(5):363-367.
doi: 10.5603/EP.2013.0019 URL |
[7] |
Calhoun DA, Nishizaka MK, Zaman MA, et al. Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea[J]. Chest, 2004, 125(1):112-117.
pmid: 14718429 |
[8] |
Di Murro A, Petramala L, Cotesta D, et al. Renin-angiotensin-aldosterone system in patients with sleep apnoea: prevalence of primary aldosteronism[J]. J Renin Angiotensin Aldosterone Syst, 2010, 11(3):165-172.
doi: 10.1177/1470320310366581 URL |
[9] |
Li M, Ge Q, Sheng CS, et al. Clinical characteristics of snoring patients with primary aldosteronism and obstructive sleep apnea-hypopnea syndrome[J]. J Hum Hypertens, 2019, 33(9):693-700.
doi: 10.1038/s41371-019-0208-9 URL |
[10] |
Monticone S, D'Ascenzo F, Moretti C, et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis[J]. Lancet Diabetes Endocrinol, 2018, 6(1):41-50.
doi: 10.1016/S2213-8587(17)30319-4 URL |
[11] |
Milliez P, Girerd X, Plouin PF, et al. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism[J]. J Am Coll Cardiol, 2005, 45(8):1243-1248.
pmid: 15837256 |
[12] |
Rossi GP, Maiolino G, Flego A, et al. Adrenalectomy lowers incident atrial fibrillation in primary aldosteronism patients at long term[J]. Hypertension, 2018, 71(4):585-591.
doi: 10.1161/HYPERTENSIONAHA.117.10596 URL |
[13] |
Rossi GP, Cesari M, Cuspidi C, et al. Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism[J]. Hypertension, 2013, 62(1):62-69.
doi: 10.1161/HYPERTENSIONAHA.113.01316 URL |
[14] |
Zhu L, Zhang Y, Zhang H, et al. Comparison between adrenal venous sampling and computed tomography in the diagnosis of primary aldosteronism and in the guidance of adrenalectomy[J]. Medicine (Baltimore), 2016, 95(39):e4986.
doi: 10.1097/MD.0000000000004986 URL |
[15] | Fassnacht M, Arlt W, Bancos I, et al. Management of adrenal incidentalomas: European Society of Endocrino-logy Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors[J]. Eur J Endocrinol, 2016, 175(2):G1-G34. |
[16] | 中华医学会内分泌学分会肾上腺学组. 原发性醛固酮增多症诊断治疗的专家共识[J]. 中华内分泌代谢杂志, 2020, 36(9):727-736. |
[17] | Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines[J]. Hypertension, 2018, 71(6):e13-e115. |
[18] | 冷敏, 刘爱云, 司家峰, 等. 化学发光法检测鲁西健康人群肾素-血管紧张素-醛固酮系统参考范围及影响因素[J]. 国际检验医学杂志, 2018, 39(15):1910-1914. |
[19] |
Funder JW, Carey RM, Mantero F, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline[J]. J Clin Endocrinol Metab, 2016, 101(5):1889-1916.
doi: 10.1210/jc.2015-4061 pmid: 26934393 |
[1] | . [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(05): 460-468. |
[2] | CHENG Yibang, LI Mingxuan, CHEN Bo, CAO Sheng, JIANG Gonghao, XU Jianzhong, LI Yan, WANG Jiguang. Diagnostic value of measuring the plasma renin and aldosterone by chemiluminescence immunoassay in the primary aldosteronism [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(05): 474-480. |
[3] | LI Zhoutong, ZHANG Wei, WANG Jiguang. Accuracy of home versus ambulatory blood pressure monitoring in the diagnosis of white-coat and masked hypertension [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(05): 487-493. |
[4] | . [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(05): 525-527. |
[5] | . [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(05): 528-530. |
[6] | . [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(05): 445-449. |
[7] | . [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(05): 454-459. |
[8] | HUANG Yongyan, YANG Lina, CAO Jiumei, WANG Wei. Cloud-based solution assisted blood pressure management in outpatient setting [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(03): 319-324. |
[9] | WANG Yajuan, GUO Qianhui, ZHANG Dongyan, CHENG Yibang, CHEN Ling, ZHU Dingliang, LI Yan. Prevalence of overweight and obesity and analysis of blood pressure related factors among children and adolescents in Xinzhuang community, Shanghai [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(05): 575-580. |
[10] | HUANG Jianfeng, SHENG Changsheng, HUANG Qifang, CHENG Yibang, GUO Qianhui, ZHANG Dongyan, WANG Jiguang, LI Yan. Study on circadian blood pressure rhythmandrelated influencing factors in outpatients [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(03): 313-318. |
[11] | WEI Jian, GAO Pingjin, HAN Weiqing. Effect of α7 nicotinic acetylcholine receptor activation on transforming growth factor β1-induced phenotypic transformation of adventitia fibroblasts studied in vitro [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(1): 56-60. |
[12] | GUO Tongshuai, CHU Chao, WANG Yang, REN Keyu, MU Jianjun. Effects of salt loading and potassium supplement on circadian blood pressure profile in salt-sensitive Chinese subjects [J]. Journal of Diagnostics Concepts & Practice, 2017, 16(06): 582-586. |
[13] | . [J]. Journal of Diagnostics Concepts & Practice, 2017, 16(06): 567-570. |
[14] | CHEN Hui, GUO Qianhui, XU Jie, CHENG Yibang, ZHANG Dongyan, WANG Ying, HUANG Qifang, SHENG Changsheng, LI Yan. Prevalence and determinants of asymptomatic intracranial artery stenosis assessed by transcranial Doppler ultrosonography [J]. Journal of Diagnostics Concepts & Practice, 2017, 16(06): 592-595. |
[15] | . [J]. Journal of Diagnostics Concepts & Practice, 2017, 16(06): 576-581. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||